Ed Scolnick

Ed Scolnick

Direttore/Membro del Consiglio presso
Massachusetts Institute of Technology
85 anni
Health Technology
Commercial Services
Finance

Profilo

Ed M.
Scolnick
is currently the Director at Massachusetts Institute of Technology, and a Member of the National Academy of Sciences, American Academy of Arts & Sciences, and National Academy of Medicine.
He previously served as Director at EMD Millipore Corp., Renovis, Inc., Hypnion, Inc., Link Medicine Corp., and Chiasma, Inc. He was also a Director at Alnylam Pharmaceuticals, Inc. from 2008 to 2010.
Additionally, he served as Senior Vice President-Cell Biology Research at Merck & Co., Inc. from 1982 to 2002, and as President of Merck Research Laboratories Massachusetts LLC from 1982 to 2003.
He was also a Director at the US Food & Drug Administration and National Cancer Institute.
Dr. Scolnick received his undergraduate degree in 1961 and doctorate in 1965 from Harvard University.

Posizioni attive di Ed Scolnick

SocietàPosizioneInizio
Direttore/Membro del Consiglio -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Precedenti posizioni note di Ed Scolnick

SocietàPosizioneFine
Direttore/Membro del Consiglio 15/07/2010
ALNYLAM PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 01/02/2010
Investitore di Private Equity 30/06/2008
Direttore/Membro del Consiglio 20/07/2005
Presidente 01/01/2003
Vedi nel dettaglio l'esperienza di Ed Scolnick

Formazione di Ed Scolnick

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

93

Relazioni di 1° grado

17

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private17

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Finance

Health Services

Miscellaneous

Government

Commercial Services

Commercial Services

Commercial Services

Health Technology

  1. Mercati
  2. Insiders
  3. Ed Scolnick
-40%: Proroga eccezionale
g
:
:
ENTRA ORA